CHGG spent the week climbing 16% into its Q1 print. The report beat estimates. Then the Q2 revenue guide came in roughly 15% below consensus, and the stock dropped more than 11% in after-hours trading. That is the core tension: good enough on the rear view, insufficient on the forward look.
The positioning data tells a story of growing caution heading into earnings. Short interest has built steadily, now running at 6.5% of the free float — up roughly 18% from late April levels, when shares outstanding on loan jumped sharply around April 24. The borrow market itself is relaxed: the lending pool is wide open, with cost to borrow barely above 0.5% and falling, down roughly 12% on the week and 20% over the past month. That means shorts are not under any squeeze pressure — cheap to borrow, plenty of capacity. Options carry slightly more defensiveness than usual, with the put/call ratio at 0.08, about 1.4 standard deviations above its 20-day average, nudging toward the more cautious end of its recent range. None of this signals a crowded or extreme positioning; it looks measured.
The Street was already cautious before tonight's guide. The most recent action from a bellwether came from Needham's Ryan MacDonald in February, who reiterated Hold following the prior quarter's brutal −15% day-one reaction. JPMorgan downgraded to Underweight in April 2025. Morgan Stanley moved to Underweight in January 2025, with a $1.25 target that now sits near the current price. The return potential implied by analyst consensus is negative at −33%, one of the more bearish Street setups in the education services space. The bear case centres on a revenue base that fell 30% year-on-year in Q1 2025, an operating margin that was negative, and Q2 subscription revenue guidance coming in well below what analysts modelled. The bull case rests on cost savings: management has guided for $100–110 million in non-GAAP savings in 2026, plus $120 million from restructuring. Whether that is enough to stabilise the business in a world where generative AI is commoditising the study-tool market remains the central debate.
CEO Daniel Rosensweig holds the largest single disclosed stake at nearly 6.9% of shares. In February he bought 100,000 shares at $0.56, a small but symbolically meaningful purchase at a multi-year low. CFO David Longo, by contrast, sold 63,600 shares in April at $0.80. The net insider position over the past 90 days shows modest net buying of roughly 435,000 shares, but the value involved — around $355,000 — is not material at the institutional level. The largest institutional holder, Vanguard, recently added about 195,000 shares, while Arrowstreet trimmed by over 1.1 million. Galloway Capital Partners is worth noting: they reported a fresh 3.1 million share position in early April, representing a new entry.
The last earnings reaction is the sharpest reference point. When Chegg reported Q4 2025 results in February, the stock fell 14.9% on the day and extended to −31.6% over the following five sessions. Tonight's Q2 guide — revenues of $49–$50 million against a $58.6 million consensus estimate — delivered a similar shock. With the RSI already elevated at 71 heading into the report, the stock had priced in some recovery. The after-hours drop suggests the market needed a better forward trajectory, not just a backward beat.
The next formal event is a Q1 2026 earnings call flagged for May 11. The after-hours reaction has likely already set the tone, but management commentary around the cost-cutting path, AI strategy, and whether the subscription base has found a floor will define how short interest and analyst targets move from here.
See the live data behind this article on ORTEX.
Open CHGG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
